Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients

Brain, Behavior, and Immunity

Volumn 23, Issue 8, 2009, Pages 1125-1131

  Garcia M G ^a   Puig, J G ^a   Torres, R J ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Adenosine; Dopamine; HPRT; Lesch Nyhan; Obsessive compulsive behavior

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; HYPOXANTHINE; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; LESCH NYHAN SYNDROME; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADENOSINE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; HYPOXANTHINE; LESCH-NYHAN SYNDROME; LYMPHOCYTES; RECEPTORS, ADENOSINE A2; RECEPTORS, DOPAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 72649095575     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.07.006     Document Type: Article

References (50)

1. Albin R.L., and Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci. 29 (2006) 175-182
2. Barbanti P., Fabbrini G., Ricci A., Bruno G., Cerbo R., Bronzetti E., Amenta F., and Luigi Lenzi G. Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease. Mech. Ageing Dev. 120 (2000) 65-75
3. Bertelli M., Cecchin S., Lapucci C., Jacomelli G., Jinnah H.A., Pandolfo M., and Micheli V. Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease). Clin. Chim. Acta 373 (2006) 104-107
4. Bondy B., and Ackenheil M. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia. J. Psychiatry Res. 21 (1987) 521-529
5. Bondy B., Ackenheil M., Birzle W., Elbers R., and Fröhler M. Catecholamines and their receptors in blood: evidence for alterations in schizophrenia. Biol. Psychiatry 19 (1984) 1377-1393
6. Bondy B., Ackenheil M., Elbers R., and Fröhler M. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia?. Psychiatry Res. 15 (1985) 41-48
7. Boyum A. Separation of white blood cells. Nature 204 (1964) 793-794
8. Brosh S., Boer P., Kupfer B., de Vries A., and Sperling O. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency. J. Clin. Invest. 58 (1976) 289-297
9. Carter A.S., Pauls D.L., Leckman J.F., and Cohen D.J. A prospective longitudinal study of Giles de la Tourette's syndrome. J. Am. Acad. Child Adolesc. Psychiatry 33 (1994) 377-385
10. Czermak C., Lehofer M., Renger H., Wagner E.M., Lemonis L., Rohrhofer A., Schauenstein K., and Liebmann P.M. Dopamine receptor D3 mRNA expression in human lymphocytes is negatively correlated with the personality trait of persistence. J. Neuroimmunol. 150 (2004) 145-149
11. Ernst M., Zametkin A.J., Matochik J.A., Pascualvaca D., Jons P.H., Hardy K., Hankerson J.G., Doudet D.J., and Cohen R.M. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N. Engl. J. Med. 334 (1996) 1568-1572
12. Ferrari M., Termine C., Franciotta D., Castiglioni E., Pagani A., Lanzi G., Marino F., Lecchini S., Cosentino M., and Balottin U. Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients. J. Psychiatry Res. 43 (2008) 24-29
13. Ferré S., Fredholm B.B., Morelli M., Popoli P., and Fuxe K. Adenosine-dopamine receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20 (1997) 482-487
14. 2 dopamine receptors in rat striatum. Brain Res. Mol. Brain Res. 14 (1992) 186-195
15. Fuxe K., Ferré S., Genedani S., Franco R., and Agnati L.F. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol. Behav. 92 (2007) 210-217
16. García Puig J., Torres Jiménez R., Mateos F., Ramos T., Arcas J., Buño A., and ÓNeill P. The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families. Medicine (Baltimore) 80 10 (2001) 2-112
17. Gessi S., Varani K., Merighi S., Cattabriga E., Pancaldi C., Szabadkai Y., Rizzuto R., Klotz K.N., Leung E., Mac Lennan S., Baraldi P.G., and Borea P.A. Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20. Mol. Pharmacol. 67 (2005) 2137-2147
18. Greenwood T.A., Alexander M., Keck P.E., McElroy S., Sadovnick A.D., Remick R.A., and Kelsoe J.R. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am. J. Med. Genet. 105 (2001) 145-151
19. Ilani T., Ben-Shachar D., Strous R.D., Mazor M., Sheinkman A., Kotler M., and Fuchs S. A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc. Natl. Acad. Sci. USA 98 (2001) 625-628
20. Jankovic J., Caskey T.C., Stout J.T., and Butler I.J. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann. Neurol. 23 (1988) 466-469
21. Jinnah H.A., Visser J.E., Harris J.C., Verdu A., Larovere L., Ceballos-Picot I., Gonzalez-Alegre P., Neychev V., Torres R.J., Dulac O., Desguerre I., Schretlen D.J., Robey K.L., Barabas G., Bloem B.R., Nyhan W., De Kremer R., Eddey G.E., Puig J.G., Reich S.G., and Lesch-Nyhan Disease International Study Group. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 129 (2006) 1201-1217
22. Kirillova G.P., Hrutkay R.J., Shurin M.R., Shurin G.V., Tourkova I.L., and Vanyukov M.M. Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays. J. Neurosci. Methods 174 (2008) 272-280
23. Koshiba M., Rosin D.L., Hayashi N., Linden J., and Sitkovsky M.V. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol. Pharmacol. 55 (1999) 614-624
24. Kurlan R., Como P.G., Miller B., Palumbo D., Deeley C., Andersen E.M., Eapen S., and McDermott M.P. The behavioral spectrum of tic disorders: a community-based study. Neurology 59 (2002) 414-420
25. Kwak Y.T., Koo M.S., Choi C.H., and Sunwoo I. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med. Genet. 2 (2001) 3
26. Laasonen-Balk T., Kuikka J., Viinamäki H., Husso-Saastamoinen M., Lehtonen J., and Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology (Berlin) 144 28 (1999) 282-285
27. Lesch M., and Nyhan W.L. A familial disorder of uric acid metabolism and central nervous system function. Am. J. Med. 36 (1964) 561-570
28. Lloyd K.G., Hornykiewicz O., Davidson L., Shannak K., Farley I., Goldstein M., Shibuya M., Kelley W.N., and Fox I.H. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N. Engl. J. Med. 305 (1981) 1106-1111
29. McKenna F., McLaughlin P.J., Lewis B.J., Sibbring G.C., Cummerson J.A., Bowen-Jones D., and Moots R.J. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J. Neuroimmunol. 132 (2002) 34-40
30. Mirabet M., Herrera C., Cordero O.J., Mallol J., Lluis C., and Franco R. Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. J. Cell Sci. 112 (1999) 491-502
31. Moroz C., Bessler H., Djaldetti M., and Stevens R.H. Human adenosine receptor bearing lymphocytes: enumeration, characterization, and distribution in peripheral blood lymphocytes. Clin. Immunol. Immunopathol. 18 (1981) 47-53
32. Nagai Y., Ueno S., Saeki Y., Soga F., Hirano M., and Yanagihara T. Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology 46 (1996) 791-795
33. Ostadali M.R., Ahangari G., Eslami M.B., Razavi A., Zarrindast M.R., Ahmadkhaniha H.R., and Boulhari J. The detection of dopamine gene receptors (DRD1-DRD5) expression on human peripheral blood lymphocytes by real time PCR. Iran J. Allergy Asthma Immunol. 3 (2004) 169-174
34. Padín J.F., Rodríguez M.A., Domínguez E., Dopeso-Reyes I.G., Buceta M., Cano E., Sotelo E., Brea J., Caruncho H.J., Isabel Cadavid M., Castro M., and Isabel Loza M. Parallel regulation by olanzapine of the patterns of expression of 5-HT2A and D3 receptors in rat central nervous system and blood cells. Neuropharmacology 51 (2006) 923-932
35. Prior C., Torres R.J., and Puig J.G. Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients. Eur. J. Clin. Invest. 37 (2007) 905-911
36. Rasmussen R. Quantification on the LightCycler. In: Meuer S., Wittwer C., and Nakagawara K. (Eds). Rapid Cycle Real-time PCR Methods and Applications (2001), Springer Press, Heidelberg 21-34
37. Rocc P., De Leo C., Eva C., Marchiaro L., Milani A.M., Musso R., Ravizza L., Sanadla E., and Bogetto F. Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 1155-1160
38. Saito, Y., Takashima, S., 2000. Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain Dev. (Suppl. 1), S122-S131 (Review).
39. Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., Rommelspacher H., and Schmidt L.G. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiatry 41 (1997) 299-304
40. Schretlen D.J., Harris J.C., Park K.S., Jinnah H.A., and del Pozo N.O. Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency. J. Int. Neuropsychol. Soc. 7 (2001) 805-812
41. Schultz V., and Lowenstein J.M. Purine nucleotide cycle. Evidence for the occurrence of the cycle in brain. J. Biol. Chem. 251 (1976) 485-492
42. Seegmiller J.E., Rosenbloom F.M., and Kelley W.N. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155 (1967) 1682-1684
43. Silverstein F.S., Johnston M.V., Hutchinson R.J., and Edwards N.L. Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities. Neurology 35 (1985) 907-911
44. Spencer T., Biederman J., Coffey B., Geller D., Faraone S., and Wilens T. Tourette disorder and ADHD. Adv. Neurol. 85 (2001) 57-77
45. Torres R.J., Deantonio I., Prior C., and Puig J.G. Adenosine transport in peripheral blood lymphocytes from Lesch-Nyhan patients. Biochem. J. 377 (2004) 733-739
46. Ueno S., Nakamura M., Mikami M., Kondoh K., Ishiguro H., Arinami T., Komiyama T., Mitsushio H., Sano A., and Tanabe H. Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol. Psychiatry 4 (1999) 552-557
47. Watts R.W., Spellacy E., Gibbs D.A., Allsop J., McKeran R.O., and Slavin G.E. Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the Neurological manifestations. Q. J. Med. 51 (1982) 43-78
48. Wong D.F., Harris J.C., Naidu S., Yokoi F., Marenco S., Dannals R.F., Ravert H.T., Yaster M., Evans A., Rousset O., Bryan R.N., Gjedde A., Kuhar M.J., and Breese G.R. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc. Natl. Acad. Sci. USA 93 (1996) 5539-5543
49. Yang B., Chan R.C., Jing J., Li T., Sham P., and Chen R.Y. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 (2007) 541-550
50. Zoref-Shani E., Bromberg Y., Brosh S., Sidi Y., and Sperling O. Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient rat neuroma cell line. J. Neurochem. 61 (1993) 457-463